CIK 0000872589 · Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- operating
- EIN
- 133444607
- Phone
- 9148477000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $51,901,544
- in 11 filings, $8.6M under 10b5-1 plans
Net −$51,901,544. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-08 | Pitofsky Jason VP Controller | Shares withheld for taxes | −989 | $712.94 | $705K | 5,308 |
| 2025-12-08 | MURPHY ANDREW J EVP Research | Shares withheld for taxes | −1,699 | $712.94 | $1.2M | 52,062 |
| 2025-12-08 | Fenimore Christopher R. EVP Finance CFO | Shares withheld for taxes | −992 | $712.94 | $707K | 18,300 |
| 2025-12-08 | McCourt Marion EVP Commercial | Shares withheld for taxes | −1,336 | $712.94 | $952K | 15,370 |
| 2025-12-08 | Van Plew Daniel P EVP & General Mgr, Industrial | Shares withheld for taxes | −1,906 | $712.94 | $1.4M | 24,225 |
| 2025-12-08 | LAROSA JOSEPH J EVP General Counsel and Secret | Shares withheld for taxes | −1,396 | $712.94 | $995K | 29,517 |
| 2025-12-05 | Pitofsky Jason VP Controller | Grant or award | +2,064 | 6,297 | ||
| 2025-12-05 | Pitofsky Jason VP Controller | Grant or award · Non-Qualified Stock Option (right to buy) | +2,261 | 2,261 | ||
| 2025-12-05 | MURPHY ANDREW J EVP Research | Grant or award | +3,715 | 53,761 | ||
| 2025-12-05 | MURPHY ANDREW J EVP Research | Grant or award · Non-Qualified Stock Option (right to buy) | +18,315 | 18,315 | ||
| 2025-12-05 | Fenimore Christopher R. EVP Finance CFO | Grant or award | +3,027 | 19,292 | ||
| 2025-12-05 | Fenimore Christopher R. EVP Finance CFO | Grant or award · Non-Qualified Stock Option (right to buy) | +14,924 | 14,924 | ||
| 2025-12-05 | McCourt Marion EVP Commercial | Grant or award | +2,476 | 16,706 | ||
| 2025-12-05 | McCourt Marion EVP Commercial | Grant or award · Non-Qualified Stock Option (right to buy) | +12,210 | 12,210 | ||
| 2025-12-05 | Van Plew Daniel P EVP & General Mgr, Industrial | Grant or award | +3,715 | 26,131 | ||
| 2025-12-05 | Van Plew Daniel P EVP & General Mgr, Industrial | Grant or award · Non-Qualified Stock Option (right to buy) | +18,315 | 18,315 | ||
| 2025-12-05 | LAROSA JOSEPH J EVP General Counsel and Secret | Grant or award | +2,476 | 30,913 | ||
| 2025-12-05 | LAROSA JOSEPH J EVP General Counsel and Secret | Grant or award · Non-Qualified Stock Option (right to buy) | +12,210 | 12,210 | ||
| 2025-11-20 | Bassler Bonnie L Director | Option exercise 10b5-1 | +760 | $371.40 | $282K | 2,308 |
| 2025-11-20 | Bassler Bonnie L Director | Sale 10b5-1 | −760 | $750.00 | $570K | 1,548 |
Page 12 of 49 · 971 trades